These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 30308159

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Implications of broadly neutralizing antibodies in the development of a universal influenza vaccine.
    Cho A, Wrammert J.
    Curr Opin Virol; 2016 Apr; 17():110-115. PubMed ID: 27031684
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses.
    Wu NC, Thompson AJ, Lee JM, Su W, Arlian BM, Xie J, Lerner RA, Yen HL, Bloom JD, Wilson IA.
    Science; 2020 Jun 19; 368(6497):1335-1340. PubMed ID: 32554590
    [Abstract] [Full Text] [Related]

  • 25. In vitro evolution of an influenza broadly neutralizing antibody is modulated by hemagglutinin receptor specificity.
    Wu NC, Grande G, Turner HL, Ward AB, Xie J, Lerner RA, Wilson IA.
    Nat Commun; 2017 May 15; 8():15371. PubMed ID: 28504265
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.
    Virology; 2015 Dec 15; 486():134-45. PubMed ID: 26433051
    [Abstract] [Full Text] [Related]

  • 28. Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 influenza virus hemagglutinin.
    Dreyfus C, Ekiert DC, Wilson IA.
    J Virol; 2013 Jun 15; 87(12):7149-54. PubMed ID: 23552413
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Wang SC, Liao HY, Zhang JY, Cheng TR, Wong CH.
    Virology; 2019 Jan 02; 526():125-137. PubMed ID: 30388628
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Influenza Hemagglutinin Structures and Antibody Recognition.
    Wu NC, Wilson IA.
    Cold Spring Harb Perspect Med; 2020 Aug 03; 10(8):. PubMed ID: 31871236
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Broadly neutralizing antibodies target a haemagglutinin anchor epitope.
    Guthmiller JJ, Han J, Utset HA, Li L, Lan LY, Henry C, Stamper CT, McMahon M, O'Dell G, Fernández-Quintero ML, Freyn AW, Amanat F, Stovicek O, Gentles L, Richey ST, de la Peña AT, Rosado V, Dugan HL, Zheng NY, Tepora ME, Bitar DJ, Changrob S, Strohmeier S, Huang M, García-Sastre A, Liedl KR, Bloom JD, Nachbagauer R, Palese P, Krammer F, Coughlan L, Ward AB, Wilson PC.
    Nature; 2022 Feb 03; 602(7896):314-320. PubMed ID: 34942633
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it.
    Wang W, Vassell R, Song HS, Chen Q, Keller PW, Verma S, Alvarado-Facundo E, Wan H, Schmeisser F, Meseda CA, Weir JP, Weiss CD.
    PLoS One; 2019 Feb 03; 14(9):e0222436. PubMed ID: 31513662
    [Abstract] [Full Text] [Related]

  • 39. Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates.
    Darricarrère N, Qiu Y, Kanekiyo M, Creanga A, Gillespie RA, Moin SM, Saleh J, Sancho J, Chou TH, Zhou Y, Zhang R, Dai S, Moody A, Saunders KO, Crank MC, Mascola JR, Graham BS, Wei CJ, Nabel GJ.
    Sci Transl Med; 2021 Mar 03; 13(583):. PubMed ID: 33658355
    [Abstract] [Full Text] [Related]

  • 40. Divergent Requirement of Fc-Fcγ Receptor Interactions for In Vivo Protection against Influenza Viruses by Two Pan-H5 Hemagglutinin Antibodies.
    Wang S, Ren H, Jiang W, Chen H, Hu H, Chen Z, Zhou P.
    J Virol; 2017 Jun 01; 91(11):. PubMed ID: 28331095
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.